• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of plospathPLoS PathogensSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)View this Article
PLoS Pathog. Feb 2008; 4(2): e1000008.
Published online Feb 29, 2008. doi:  10.1371/journal.ppat.1000008
PMCID: PMC2279260

Adenylyl Cyclase α and cAMP Signaling Mediate Plasmodium Sporozoite Apical Regulated Exocytosis and Hepatocyte Infection

Kami Kim, Academic Editor

Abstract

Malaria starts with the infection of the liver of the host by Plasmodium sporozoites, the parasite form transmitted by infected mosquitoes. Sporozoites migrate through several hepatocytes by breaching their plasma membranes before finally infecting one with the formation of an internalization vacuole. Migration through host cells induces apical regulated exocytosis in sporozoites. Here we show that apical regulated exocytosis is induced by increases in cAMP in sporozoites of rodent (P. yoelii and P. berghei) and human (P. falciparum) Plasmodium species. We have generated P. berghei parasites deficient in adenylyl cyclase α (ACα), a gene containing regions with high homology to adenylyl cyclases. PbACα-deficient sporozoites do not exocytose in response to migration through host cells and present more than 50% impaired hepatocyte infectivity in vivo. These effects are specific to ACα, as re-introduction of ACα in deficient parasites resulted in complete recovery of exocytosis and infection. Our findings indicate that ACα and increases in cAMP levels are required for sporozoite apical regulated exocytosis, which is involved in sporozoite infection of hepatocytes.

Author Summary

Malaria is transmitted through the bite of an infected mosquito that deposits Plasmodium sporozoites under the skin. These sporozoites migrate from the skin into the circulation and then enter the liver to start a new infection inside hepatocytes. Sporozoites have the capacity to traverse mammalian cells. They breach their membranes and migrate through their cytosol. This process is required for infection of the liver and triggers the exposure of adhesive proteins in the apical end of sporozoites, a process that facilitates invasion of hepatocytes. We found that elevations of cAMP inside sporozoites mediate the exposure of adhesive proteins and therefore the infection process. Mutant sporozoites that do not express adenylyl cyclase, the enzyme that synthesizes cAMP, are not able to expose the adhesive proteins and their infectivity is reduced by half. Reinsertion of adenylyl cyclase gene in the mutant sporozoites recovers their capacity to expose adhesive proteins and to infect hepatocytes, confirming the specific role of this protein in infection. These results demonstrate the importance of cAMP and the exposure of adhesive proteins in sporozoites, but also show that Plasmodium sporozoites have other mechanisms to invade host hepatocytes that are not inhibited in the mutant parasites.

Introduction

Plasmodium, the causative agent of malaria, is transmitted by the bite of infected mosquitoes that inoculate the sporozoite form of the parasite in the host. Sporozoites rapidly migrate to the liver, where they infect hepatocytes, replicate and develop into merozoites, the blood-stage form of the parasite. Plasmodium belongs to the phylum apicomplexa, a group of parasites that share conserved mechanisms of motility and cell invasion machinery [1]. Apical exocytosis is another common feature that has been characterized in Toxoplasma tachyzoites [2] and sporozoites from Eimeria [3], Cryptosporidium [4] and Plasmodium [5]. This process has been most extensively studied in Toxoplasma tachyzoites, where active invasion of host cells involves the secretion of transmembrane adhesive proteins from the micronemes, which congregate on the anterior surface of the parasite and bind host receptors to mediate apical attachment [6]. One of these adhesive proteins, MIC2, which plays a central role in motility and invasion [7] is closely related to Plasmodium Thombospondin-Related Anonymous Protein, TRAP (also known as Sporozoite Surface Protein 2, SSP2) [8], which is also exposed in the apical end of the parasite upon microneme exocytosis [5],[9] and is also required for Plasmodium sporozoite motility and invasion [10].

While in Toxoplasma tachyzoites microneme secretion is strongly up-regulated upon contact with the host cell, in Plasmodium sporozoites contact with host cells is not sufficient to activate this process and migration through cells is required to induce apical regulated exocytosis [9]. Sporozoites of different human and rodent Plasmodium species have the ability to migrate through host cells. Sporozoites enter and exit cells by breaching the plasma membrane of the traversed cell. This process results in sporozoites traversing host cells by moving through their cytosol without any surrounding membranes. Ultimately, sporozoites establish infection in a final hepatocyte through formation of a vacuole within which the parasite replicates and develops [9]. Migration through host cells induces apical exocytosis in Plasmodium sporozoites, resulting in the exposure of high concentrations of TRAP/SSP2 in the apical end of the parasite [9]. This process, similarly to Toxoplasma secretion of MIC2 [7], is thought to facilitate invasion of the host cell [9].

During migration through host cells sporozoites are not surrounded by any host membranes, and as a result, they are in direct contact with the cytosol of the host cell [11]. Incubation of Plasmodium sporozoites with a lysate of host cells activates apical exocytosis in the parasite, suggesting that host cell molecules induce the activation of exocytosis in migrating parasites [9]. We have studied the role of uracil nucleotides in sporozoite exocytosis, since these molecules induce exocytosis in other cellular systems [12] and are found in the cytosol of mammalian cells in high concentrations. We found that uracil and its derived nucleoside and nucleotides (UMP, UDP and UTP) at the physiological concentrations found in the cytosol of mammalian cells, activate apical regulated exocytosis and increase the infectivity of sporozoites [13]. Since sporozoites are in contact with the cytosol of the traversed host cells, it is likely that the high concentrations of uracil derivatives that they would encounter, probably participate in the activation of sporozoites during migration through cells. Addition of uracil derivatives in vitro induces apical regulated exocytosis within the first ten minutes after addition of the stimulus [13]. In certain mammalian cell types, UTP and UDP can activate signaling cascades by binding to P2Y receptors, which in turn can activate adenylyl cyclase and increase cyclic adenosine monophosphate (cAMP) levels. Activation of P2Y receptors by nucleotides leads to exocytosis in different cells from insulin release from pancreatic islet β cells to the release of histamine from mast cells [14].

Here we have analyzed the role of the cAMP signaling pathway in sporozoite apical exocytosis and infection. We found biochemical evidences indicating that increases in cAMP levels in sporozoites mediate apical regulated exocytosis, which activates sporozoites for host cell invasion. By creating a parasite line deficient in adenylyl cyclase α (ACα), we confirmed that the cAMP signaling pathway is essential to induce apical exocytosis, which is activated during migration through cells. In addition, this recombinant parasite provides a tool to determine the precise contribution of apical exocytosis to sporozoite infection. A role for migration through cells and apical regulated exocytosis in infection was proposed before [9], but it had been questioned in view of transgenic sporozoites that were able to infect cells in vitro without performing the previous migration step [15]. Here we show that apical regulated exocytosis contributes significantly to host cell invasion, but the parasite seems to have alternative mechanisms to establish successful infections in host cells.

Results

To investigate the signaling pathways mediating Plasmodium sporozoite exocytosis, we used a mix of uracil and its derivatives (uridine, UMP, UDP and UTP) at the concentrations normally found in the cytosol of mammalian cells (described in Experimental Procedures), which induce exocytosis in sporozoites [13]. Apical regulated exocytosis has been characterized in Plasmodium sporozoites by the exposure of high concentrations of TRAP/SSP2 in the apical end of the parasite and also by the release of this protein into the medium [9]. We confirmed that exocytosis occurs at the apical end of the sporozoite by staining the trails left behind after gliding motility. Trails are always next to the posterior end because sporozoites move with their apical end in the front (Fig. S1).

We first investigated whether cAMP induces or modulates sporozoite regulated exocytosis by preincubating P. yoelii sporozoites with a membrane permeant analogue of cAMP. Exocytosis is quantified as the percentage of sporozoites that present a defined accumulation of extracellular TRAP/SSP2 in their apical end [9]. We found that 8Br-cAMP induces sporozoite exocytosis to a similar level than uracil derivatives. Addition of both stimuli to sporozoites did not increase the level of exocytosis (Fig. 1A), suggesting that both stimuli may be using the same pathway to induce exocytosis. As an alternative way to increase cytosolic cAMP in sporozoites, we used forskolin, an activator of the enzyme that synthesizes cAMP, adenylyl cyclase (AC). This treatment also induced apical regulated exocytosis in sporozoites (Fig. 1B). Incubation of sporozoites with MDL-12,330A, an inhibitor of AC [16] prevented activation of exocytosis by uracil derivatives (Fig. 1B). We confirmed that these treatments did not increased sporozoite lysis compared to control (Table S1 and Fig. S2).

Figure 1
Increases in cytosolic cAMP induce Plasmodium sporozoite exocytosis.

Genetically manipulated sporozoites that are deficient in their capacity to migrate through cells (spect-deficient) infect hepatic cell lines in vitro, questioning the role of migration through cells in the activation of sporozoites for infection [15]. To analyze the exocytosis response of these sporozoites, we stimulated them with uracil derivatives or treatments that modulate cAMP levels. Incubation of P. berghei wt or spect-deficient sporozoites with uracil derivates induced apical regulated exocytosis. However, forskolin and 8-Br-cAMP did not induce exocytosis in spect-deficient sporozoites and MDL-12,330A only has a partial effect in the inhibition of exocytosis (Fig. 1C). These results suggest that, in contrast to wt P. berghei sporozoites, spect-deficient sporozoites do not use cAMP-mediated signaling pathways to activate exocytosis.

We have used the rodent malaria parasites P. yoelii and P. berghei as a model for P. falciparum, the human parasite responsible for the mortality associated with this disease. P. falciparum sporozoites also migrate through host cells [11], a process that induces apical regulated exocytosis in this species of the parasite [13]. Similar to the rodent parasites, uracil and its derivatives induce exocytosis in P. falciparum sporozoites [13]. We found that elevated cAMP levels also induce exocytosis in P. falciparum sporozoites and that exocytosis induced by uracil derivatives is inhibited by MDL-12,330A (Fig. 1D), suggesting that this pathway is conserved in the human and murine parasites.

To directly demonstrate that cAMP levels are increased in P. yoelii sporozoites in response to exocytosis-inducing stimuli, we measured cAMP concentration in sporozoites after incubation with uracil derivatives. Salivary glands dissected from uninfected mosquitoes and processed in a similar way, were used as negative control. We found that uracil derivatives significantly increase the levels of cAMP in sporozoites (Fig. 1E). No increases were found when control material from uninfected mosquitoes was stimulated with uracil derivatives (not shown).

Migration through host cells induces sporozoite apical regulated exocytosis, which activates sporozoites for infection. Stimulation of exocytosis by other means, such as host cells lysate [9] or uracil derivatives [13], overcomes the need for extensive migration through cells and increases infection. To test whether stimulation of exocytosis by increases in intracellular cAMP in the sporozoite would also overcome the need for migration through host cells before infection, we incubated P. yoelii sporozoites with forskolin or 8Br-cAMP to induce regulated exocytosis before addition of sporozoites to intact Hepa1-6 cells. Migration through host cells is determined as the percentage of cells that are wounded by sporozoite migration and as a result become positive for a soluble impermeant tracer (dextran) [17]. We found an increase in the number of infected cells, indicating that stimulation of regulated exocytosis by cAMP in sporozoites increases their infectivity (Fig. 2A, black bars). In addition, activation of sporozoite exocytosis with increased cAMP levels reduces sporozoite migration through host cells, confirming that such extensive migration is no longer necessary when exocytosis is induced by elevations in the level of cAMP (Fig. 2A, white bars). These results indicate that cAMP-induced exocytosis contributes to the activation of sporozoites for infection.

Figure 2
Stimulation of exocytosis increases sporozoite infection and decreases migration through host cells.

Since sporozoites appear to activate the cAMP signaling cascade to stimulate apical regulated exocytosis, inhibition of cAMP production in sporozoites by MDL-12,330A, the inhibitor of AC, should decrease their infectivity. We actually found a significant reduction in their infectivity after treatment with this inhibitor (Fig. 2B). MDL-12.330A does not appear to have a toxic effect on sporozoites, since migration through cells was not affected (Fig. 2B).

We also observed that gliding motility of sporozoites is greatly decreased 18 to 24 min after addition of the exocytosis inducing stimulus (UD or forskolin), but not during earlier time points, while exocytosis is presumably occurring (0 to 8 min after addition of the stimulus) (Fig. S3).

The major downstream effector of cAMP is protein kinase A (PKA), a serine/threonine kinase that activates other kinases and transcription factors in the cell. This protein is likely to be present in Plasmodium because PKA activity has been detected in P. falciparum during the blood stage of the parasite [18],[19] and there is a gene sequence with high homology to PKA expressed in P. falciparum and conserved in all species of Plasmodium analyzed [20],[21], however no functional assays have yet determined the PKA activity of this putative protein. To investigate whether sporozoite exocytosis is mediated by PKA activity, we treated sporozoites with H89, a PKA inhibitor already shown to inhibit this kinase in a different stage of the parasite [18],[19]. We found that H89 inhibits sporozoite exocytosis induced by uracil derivatives (Fig. 3A), suggesting that this process is mediated by the activation of PKA. The infectivity of sporozoites pretreated with H89 is reduced, probably as a consequence of the inhibition of exocytosis (Fig. 3B), while parasite migration through host cells is not affected, confirming that H89 treatment is not toxic for sporozoites (Fig. 3C).

Figure 3
Treatment with an inhibitor of PKA reduces sporozoite exocytosis and infection.

Activation of PKA should occur after cAMP has been generated in the signaling cascade. To analyze this step of the pathway, we pretreated sporozoites with H89 before increasing cAMP levels with the addition of 8Br-cAMP. As expected, we found that exocytosis was completely inhibited (Fig. 3D), suggesting that PKA is activated down-stream of cAMP. Incubation of sporozoites with genistein, an inhibitor of tyrosine kinases, did not affect regulated exocytosis (Fig. 3E), indicating that tyrosine kinases are not involved in the signaling cascade. In fact, no sequences with homology to tyrosine kinases have been found in the Plasmodium genome [20].

To strengthen the evidence that the cAMP signaling pathway mediates the activation of exocytosis in sporozoites and reduce the probability of inhibitors affecting exocytosis due to non-characterized effects of the drugs, we used alternative inhibitors with unrelated chemical structures from the ones used before to inhibit adenylyl cyclase and PKA. We found similar inhibitory results using 2′, 5′-Dideoxyadenosine or SQ22536, which inhibit adenylyl cyclase. The addition of a competitive inhibitor of cAMP (cAMP Rp-isomer), which inhibits PKA, also results in inhibition of apical regulated exocytosis in sporozoites (Fig. 3F).

Since cAMP signaling appears to mediate the activation of apical exocytosis, we searched for ACs in the malaria genome. Two different genes with high homology to ACs (ACα and ACβ) have been identified in Plasmodium. In particular, ACα was shown to have AC activity in P. falciparum [22],[23]. Interestingly, ACα genes from Plasmodium, Paramecium and Tetrahimena are closely related and their sequence includes a domain with high homology to K+ channels [23]. In Paramecium, where the purified AC protein also has K+ channel activity, generation of cAMP is regulated by K+ conductance [24]. It is thought that ACα presents a transmembrane K+-channel domain and an intracellular AC domain, which are functionally linked [25].

Since cAMP in Plasmodium sporozoites induces apical exocytosis, we first tested whether extracellular K+ is required for this process. In fact, sporozoites must remain in a high K+ environment during migration through cells, because the cytosol of eukaryotic cells has high concentrations of this ion [26]. The existence of K+ channels has been predicted for Plasmodium parasites from electrophysiological [27] and genomic sequence data [20].

To determine whether extracellular K+ is required for sporozoite exocytosis, we stimulated exocytosis in P. yoelii sporozoites in regular medium (containing K+) or in K+-free medium. We found that exocytosis stimulated with uracil derivatives was inhibited in K+-free medium (Fig. 4A). To confirm that sporozoites were not impaired by the incubation in K+-free medium, we transferred sporozoites to regular medium after the K+-free medium incubation. We found that exocytosis in these sporozoites was similar to exocytosis in sporozoites that were never incubated in K+-free medium (Fig. 4B).

Figure 4
Extracellular K+ is required for sporozoite apical regulated exocytosis.

Exocytosis was inhibited when sporozoites were pre-incubated with different K+-channel inhibitors (Fig. 4C,D), suggesting that K+ is required for the activation of exocytosis. We also analyzed the requirement for extracellular K+ in sporozoite exocytosis induced by 8Br-cAMP or forskolin. We found that in these cases extracellular K+ is not required (Fig. 4E,F), suggesting that extracellular K+ is required upstream cAMP in the signaling cascade. Removal of K+ from the medium may alter the electrochemical gradient of sporozoites affecting UD-induced exocytosis. However, since the response to forskolin and 8Br-cAMP in K+ free medium is not affected, it suggests that the sporozoite exocytosis pathway is perfectly functional in the absence of extracellular K+. Also, the viability (Table S1) and capacity of exocytosis response (Fig. 4B) of sporozoites after this treatment was found to be unaffected.

A Ca++ ionophore can induce apical regulated exocytosis in P. yoelii [9], suggesting that Ca++ signaling may be involved in exocytosis. We first compared the magnitude of the cAMP-induced to the Ca++-induced exocytosis, finding similar results (Fig. 4G). To study whether Ca++ is also involved in the signaling induced by UD, we induced exocytosis with UD in Ca++-free medium. We found that exocytosis is not inhibited in Ca++-free medium (Fig. 4H), suggesting that extracellular Ca++ is not required for this process. However, we found a strong inhibition of exocytosis when sporozoites were incubated with a membrane-permeant Ca++ chelator, suggesting that intracellular Ca++ is required for exocytosis (Fig. 4I). A possible model for the signaling mediating exocytosis is proposed (Fig. 4J).

Since Plasmodium sporozoite regulated exocytosis requires both extracellular K+ and cAMP, we decided to test whether ACα is involved in the process of sporozoite exocytosis and activation for infection by producing recombinant parasites deficient for this enzyme. We identified the sequence encoding PbACα, the P. berghei orthologue of PfACα, in the PlasmoDB database (http://www.plasmoDB.org/). Complete PbACα sequences were retrieved from Sanger sequencing genomics project (http://www.sanger.ac.uk/). We found that PbACα is 60% identical to PfACα at the amino-acid level of the full-length predicted protein, and 79% in the AC catalytic domain.

Microarray analysis had detected expression of PfACα in sporozoites [28]. To analyze the expression of PbACα, we isolated mRNA from P. berghei sporozoites and performed reverse transcription followed by PCR. We also found expression of this gene in sporozoites (Fig. 5A). Thus, we decided to pursue a targeted gene disruption at the blood stages to study the importance of ACα for the Plasmodium pre-erythrocytic life cycle stages. We created two independent cloned lines of P. berghei parasites that are deficient in ACα (PbACα-) by using targeted disruption of the ACα gene through double crossover homologous recombination (Fig. 5B). PbACα-deficiency of the mutant parasites was confirmed by RT-PCR and Southern Blotting (Fig. 5C).

Figure 5
Generation of PbACα- parasite lines.

We examined the phenotype of PbACα- parasites during the Plasmodium life cycle. We compared the two PbACα- lines with WT P. berghei parasites also cloned independently. PbACα- parasites were indistinguishable from WT parasites in growth during red blood cell stages in mice (Fig. 6A). We next analyzed parasite growth in the mosquito by determining oocyst development and sporozoite salivary gland invasion. Similar oocyst and salivary gland sporozoite numbers were obtained for PbACα- and the WT control, indicating that PbACα is not involved in oocyst development and sporozoite salivary gland invasion (Table 1).

Figure 6
PbACα- has normal blood-stage growth rates and sporozoite motility.

Gliding motility, the characteristic form of substrate-dependent locomotion of salivary gland sporozoites, was unaffected in PbACα- parasites. Stimulation of gliding motility with albumin [29] was also similar in WT and PbACα- sporozoites (Fig. 6B). We also tested whether deletion of the ACα gene affect sporozoites ability to migrate through cells. We found that the cell-traversal activity of PbACα- sporozoites was slightly lower, but not significantly different from WT sporozoites (Fig. 6C).

We then tested whether apical regulated exocytosis was affected in PbACα-sporozoites. Activation of exocytosis by the mix of uracil derivatives or by forskolin, was greatly reduced in the two different clones of PbACα- sporozoites analyzed (Fig. 7A). Addition of a membrane permeant analogue of cAMP (8-Br-cAMP), which induces exocytosis in WT parasites, also stimulated exocytosis in PbACα- sporozoites (Fig. 7B). This result indicates that all sporozoite components required for exocytosis downstream of cAMP are functional in PbACα- sporozoites; however, the lack of ACα inhibits proper response upon activation with uracil derivatives or activators of AC activity. Migration through host cells induces apical regulated exocytosis in Plasmodium sporozoites [9]. To confirm that ACα is also required for exocytosis stimulated by migration through hepatocytes, we measured the response of WT and PbACα- sporozoites after migration through Hepa1-6 cells. We found that regulated exocytosis was not activated in sporozoites deficient in ACα (Fig. 7C).

Figure 7
PbACα- sporozoites have defective exocytosis and infection.

To examine the role of apical regulated exocytosis and ACα in sporozoite infection, we first analyzed the infectivity of PbACα- sporozoites in vitro using Hepa1-6 cells. We found that PbACα- sporozoites are approximately 50% less infective than WT sporozoites (Fig. 7D). As the infectivity of Plasmodium sporozoites can be noticeably different depending on each particular mosquito infection, we repeated the experiment using sporozoites from three different batches of infected mosquitoes. Similar results were found, confirming that PbACα- sporozoites have reduced infectivity in hepatocytes (not shown).

We also tested the infectivity of PbACα- parasites in vivo in C57/Bl6 mice, which are highly susceptible to infection by P. berghei sporozoites [30]. To quantify the infectivity of PbACα-, we used real time PCR to measure parasite load in the liver by determining the levels of the parasite-specific 18 S rRNA [31]. Remarkably, 50% decrease of parasite rRNA was detected by this method (Fig. 7E). We repeated the experiment using sporozoites from three different batches of infected mosquitoes finding similar results (not shown). These results suggest that Plasmodium sporozoites use apical regulated exocytosis to infect host cells and that ACα is an important protein involved in Plasmodium liver infection.

To confirm that the phenotype observed in the PbACα- sporozoites is caused specifically by depletion of the PbACα gene, we complemented one of the PbACα- parasite lines with ACα. The correct replacement event was confirmed by PCR and Southern blot hybridization (Fig. 8A). No differences were found between the complemented parasite line and WT or PbACα- parasites during blood stage infection in mice or in mosquito oocyst development and salivary gland sporozoite numbers (not shown). We found that apical regulated exocytosis response to uracil derivatives was recovered in the complemented sporozoites (Fig. 8B). The infectivity of sporozoites was restored by complementation of the PbACα gene (Fig. 8C), confirming the role of PbACα in sporozoite exocytosis and infection.

Figure 8
PbACα- complemented sporozoites recover the WT phenotype.

Discussion

The role of exocytosis of apical organelles in invasion of host cells has been extensively studied in Toxoplasma tachyzoites. Our knowledge of Plasmodium sporozoite exocytosis and infection is less advanced, as this parasite stage can only be obtained by dissection of infected mosquitoes, and this procedure provides limited numbers of sporozoites. Sporozoite purification methods have been recently developed (S. L. Hoffman, personal communication) allowing us to use highly purified P. falciparum sporozoites in our studies. Gene deletion technology has opened the possibility of dissecting the role of complex pathways into their individual protein components. Using a rodent malaria model we have first identified that the cAMP signaling pathway is involved in Plasmodium sporozoite exocytosis. The similar response observed in P. falciparum sporozoites suggests that the cAMP-dependent signaling pathway leading to exocytosis is conserved in the human parasite. Based on these results, we have generated a transgenic parasite that is deficient in an essential protein in the cAMP signaling pathway. This approach allowed us to evaluate the role of apical regulated exocytosis in hepatocyte infection by sporozoites in vitro and in vivo using a mouse model.

Regulated exocytosis in mammalian cells is frequently triggered by an elevation of intracellular Ca2+ levels and is modulated by cAMP, which acts synergistically with Ca2+, but cannot induce exocytosis by itself. However, in some specific cell types exocytosis is triggered solely by elevations in cAMP concentrations [32]. Increases in cytosolic Ca2+ induced with ionophores can induce exocytosis in Plasmodium sporozoites [9], suggesting that Ca2+ stimulation is also sufficient to induce this process. The signaling pathways of Ca2+ and cAMP are interrelated inside eukaryotic cells [33]. In particular, in P. falciparum blood-stages, a cross-talk between Ca2+ and cAMP has been observed, where increases in cAMP induce the elevation of intracellular Ca2+ concentrations through the activation of PKA [18]. Our results suggest that the cAMP and Ca2+ pathways are also interconnected in the sporozoite stage and that intracellular, but not extracellular Ca2+, is required for exocytosis.

When exocytosis is inhibited by the AC or the PKA inhibitors, the reduction in sporozoite infectivity is comparatively lower than the reduction in exocytosis. Similar results were obtained with the PbACα- sporozoites, where exocytosis is reduced to background levels, but infection is reduced by 50%. Taken together these results suggest that sporozoites have alternative pathways to invade host hepatocytes that do not require apical regulated exocytosis. However, we cannot exclude the possibility that low levels of exocytosis that cannot be detected in our assays still occur in the PbACα- sporozoites and are sufficient to mediate infection of hepatocytes.

The analysis of host cell molecules required for sporozoite infection has provided evidence that sporozoites use more than one unique pathway to achieve hepatocyte infection [34], suggesting that sporozoites may take advantage of this phenomenon to overcome polymorphisms in host receptors or to escape from immune mechanisms inhibiting one particular pathway of infection.

We had previously observed that activation of sporozoite exocytosis increases their infectivity and reduces the need for migration through cells [9]. Here we confirmed that activation of exocytosis by cAMP-mediated pathways increases exocytosis infectivity reducing migration through cells. Accordingly, inhibitors of this pathway inhibit sporozoite exocytosis and decrease their infectivity. Interestingly, spect-deficient sporozoites, which do not migrate through host cells [15], responded to uracil derivatives but were not able to respond to either an activator of AC or to a permeant analogue of cAMP, suggesting that cAMP-induced signaling leading to exocytosis is different in these mutant sporozoites. The positive exocytosis response observed in the presence of the inhibitor of AC, suggests that these parasites are able to respond to uracil derivatives by activating cAMP-independent pathways that are not normally activated in wt sporozoites, where cAMP is required for exocytosis. It is still not clear how this relates to their impaired capacity to migrate through cells, but suggests that they may up-regulate the alternative mechanisms that are independent of migration through cells and exocytosis to infect hepatocytes. These results are consistent with the concept that sporozoites can use alternative pathways to invade hepatocytes, as the infection experiments with PbACα- sporozoites suggest.

Apical regulated exocytosis in the transgenic parasites deficient in ACα is dramatically decreased in response to uracil derivatives or migration through host cells, indicating that ACα is necessary to induce high levels of exocytosis and confirming the essential role of the cAMP signaling pathway in this process. Complementation of the genetically deficient parasites with the ACα gene confirms that the defect in exocytosis and infection observed in PbACα- sporozoites is caused by deletion of the ACα gene and not by other modifications resulting from the genetic manipulations of these parasites.

Two genes with high homology to ACs have been identified in the Plasmodium genome: ACα and ACβ [25]. ACα activity as an AC has been demonstrated for P. falciparum, where the catalytic domain was expressed independently [22]. A second putative AC gene, called ACβ, has been identified in the Plasmodium database. We tried to generate ACβ-deficient parasites; however the ACβ gene seems to be essential for the asexual blood-stages of Plasmodium.

ACα- sporozoites are able to stimulate exocytosis in response to the permeant analogue of cAMP, but not to forskolin, the activator of ACs, confirming that the defect is caused by the lack of a functional AC and can be compensated by artificially increasing intracellular concentrations of cAMP. The results obtained with PbACα- sporozoites also suggest that ACα is sensitive to forskolin stimulation, as the increase in exocytosis induced by this drug is lost in the genetically deficient sporozoites. Since AC activity is insensitive to forskolin in asexual blood-stages [35] and ACβ is preferentially expressed in this stage of the parasite cycle [25], it seems likely that ACβ, rather than ACα, is required for cAMP formation during erythrocyte infection. We also found that the growth of PbACα- parasites in the asexual blood-stages was indistinguishable from control, consistent with the lack of activity of ACα during this stage.

Interestingly, the ACα gene contains a N-terminal domain with high homology to voltage-gated K+ channels. Other apicomplexans and also the ciliates Paramecium and Tetrahymena have an ACα gene homologous to the one in Plasmodium [23]. In Paramecium it has been demonstrated that the purified ACα protein also has K+ channel activity, and the generation of cAMP is regulated by K+ conductance [24]. Although functional K+ channel activity has not been demonstrated for ACα in Plasmodium, our results are consistent with a role for K+ conductance in sporozoite exocytosis. Uracil derivates do not induce exocytosis in K+ free medium, but activation of AC with forskolin or addition of the permeant analogue of cAMP overcomes the requirement for extracellular K+. Therefore, it seems likely that increased K+ permeability may induce activation of ACα and synthesis of cAMP.

Materials and Methods

Host cells and parasites

Hepa 1-6 (ATCC CRL-1830), a hepatoma cell line derived from a C57L/J mouse, which is efficiently infected by rodent malaria parasites [36] was used for in vitro hepatocyte infections. Plasmodium yoelii yoelii sporozoites (cell line 17× NL), P. berghei ANKA wt and spect-1 deficient sporozoites [15] and the NF54 isolate [37] of P. falciparum were used to produce sporozoites in A. stephensi mosquitoes. Salivary glands were dissected from the mosquitoes. The P. falciparum sporozoites were extracted from the salivary glands, purified, and cryopreserved. Prior to being used in assays, the sporozoites were thawed and suspended in RPMI medium.

Uracil derivatives

Exocytosis was induced by incubation of sporozoites with a mixture of the physiological concentrations of uracil derivatives (ICN Biomedicals) consisting of 180 µM uracil, 280 µM uridine, 300 µM uracil monophosphate (UMP), 50 µM uracil diphosphate (UDP) and 30 µM uracil triphosphate (UTP) was prepared in RPMI 1640 and pH adjusted to 7.

Regulated exocytosis

Sporozoites (105 P. yoelii, P. berghei or 5 × 104 P. falciparum) were centrifuged for 5 min at 1800 × g on glass coverslips before addition of uracil derivatives or conditioned medium. After incubation at 37°C for 1 h, sporozoites were fixed with 1% paraformaldehyde for 10 min (non-permeabilizing conditions) before staining for surface TRAP/SSP2 with the monoclonal antibody (F3B5) for P. yoelii, PfSSP2.1 for P. falciparum [38] and a specific TRAP/SSP2 rabbit anti-serum for P. berghei. Sporozoite regulated exocytosis was quantified as the percentage of total sporozoites that present a TRAP/SSP2 stained ‘cap’ in their apical end. Results are expressed as the average of triplicate determinations counting at least 50 sporozoites for each condition. Background level exocytosis was measured by staining sporozoites after dissection from mosquitoes, before incubation in vitro. Background exocytosis was always lower than 8% and was subtracted from all values. All experiments were performed twice showing similar results.

Western blot

4 × 105 P. yoelii sporozoites were incubated alone or with the different exocytosis stimuli for 1 h at 37°C before spinning at 20,000 g for 10 min. The supernatants were collected and separated in a 7.5% gel in reducing conditions. After semi-dry transfer to a PDVF membrane, proteins were stained with anti-P. yoelii MTIP antiserum followed by anti-rabbit conjugated to horseradish peroxidase. Bound antibodies were detected by chemiluminescence using ECL (GE Healthcare Bio-Sciences).

Drug treatments

Sporozoites (105) were incubated with 100 µM forskolin, 100 µM MDL-12.330A, 500 µM 8Br-cAMP, 10 µM H89, 30 µM genistein, 100 nM charybdotoxin, 50 µM SQ22536, 50 µM 2′, 5′-Dideoxyadenosine, 5 µM Adenosine 3′, 5′-cyclic monophosphorothioate 8Br-Rp-isomer, 1 nM margatoxin, 20 µM BAPTA, ionomycin 1 µM (all from Calbiochem) before addition or not of uracil derivatives for 1 h, followed by fixation and quantification of exocytosis. For exocytosis assays sporozoites were pretreated with the drug for 15 min and concentrations were kept constant throughout the experiment. For infection and migration, treatment with drugs was performed for 15 min before washing and spinning sporozoites on Hepa1-6 cells grown on coverslips placed in 24-well dishes containing 1 ml of culture medium/well. For assays in K+-free medium: 105 P. yoelii sporozoites were incubated for 45 min in regular medium (RPMI 1640, that contains 5.3 mM KCl and 100 mM NaCl), K+-free medium (modified RPMI 1640 with no KCl and 110 mM NaCl to maintain osmolarity) in the presence or absence of stimulus, before fixation and quantification of exocytosis. To assay sporozoites viability after incubation in K+-free medium, sporozoites centrifuged at 20,800 g and resuspended in regular medium with uracil derivatives to induce exocytosis. All experiments were performed twice showing similar results.

Intracellular cAMP levels

Intracellular levels of cAMP in P. yoelii sporozoites were determined using a cAMP Biotrack Enzymeimmunoassay system from Amersham Bioscience. For each sample 2 × 106 P. yoelii sporozoites were incubated with uracil derivatives for 45 min at 37°C. The experiment was performed twice showing similar results.

Migration through cells and infection

Sporozoites (105 sporozoites/coverslip) were added to monolayers of 2 × 105 Hepa1-6 cells for 1 h in the presence of 1 mg/ml of rhodamine-dextran lysine fixable, 10,000 MW. Sporozoites breach the plasma membrane of host cells during migration and as a result fluorescent dextran enters in their cytosol, allowing detection of wounded cells [17]. Cells were washed and incubated for another 24 hours before fixation and staining of infected cells with the mAb (2E6) recognizing HSP70 to detect infected cells [39], followed by anti-mouse IgG-FITC antibodies. Migration through host cells is quantified as percentage (or total number) of dextran-positive cells. Infection was quantified as the number of infected cells per coverslip or per 50 microscopic fields. For transwell filter assays Hepa1-6 cells (5×105) were cultivated on 3 µm pore diameter Transwell filters (Costar, Corning, New York) until they form a continuous monolayer. Empty coverslips were placed underneath the filters. P. berghei sporozoites (2×105) were added to filter insets containing Hepa1-6 cells. Coverslips were fixed after 2 h of incubation with sporozoites, before staining for surface TRAP/SSP2. All experiments were performed twice showing similar results.

Determination of live/dead sporozoites with propidium iodide

P. yoelii sporozoites were incubated with the indicated drugs for 20 min before addition of propidium iodide (1 µg/ml) for 10 min. Sporozoites were washed and observed directly with a fluorescence microscope. Propidium iodide positive sporozoites were considered dead and quantified. At least 100 sporozoites were counted in each condition.

Motility of live sporozoites

Live P. yoelii sporozoites were observed directly under the microscope in a heated stage at 37°C before or after addition of different stimuli. As control, the same volume of medium with the same solvent used for the stimuli was added. At least one hundred sporozoites were counted in each condition and they were classified as immobile, twisting or gliding, depending on their type of motility observed.

Generation of the PbACα- parasite lines

To disrupt the ACα locus an ACα replacement vector was constructed in vector b3D.DT.^H.^Db (pL0001, MRA-770) containing the pyrimethamine-resistant Toxoplasma gondii (tg) dhfr/ts gene. To complement ACα into the genome of PbACα- parasites, a vector was constructed with the human (h) dhfr selectable marker and two fragments of 4.3kb (5′) and 0.5 kb (3′) of the ACα gene of P. berghei. The linearized vector can integrate in ACα. Further details are described in Fig. 5. P. berghei-ANKA (clone 15cy1) was used to generate PbACα-parasites. Transfection, selection, and cloning of PbACα- parasites was performed as described [40]. Two clones (C1 and C2) were selected for further analysis. PbACα- C1 parasites were transfected with the complement vector to create ACα- complement. Selection of transformed parasites was performed by treating infected animals with WR99210 (20 mg/kg bodyweight) as has been described [41]. One parasite clone (Cmp) in which the ACα gene was integrated into the ACα locus was selected for further analysis. Correct integration of constructs into the genome of transformed parasites was analyzed by RT-PCR and Southern analysis of restricted DNA. PCR on DNA of WT and ACα parasites was performed by using primers specific for the WT 5′ (flG1F 5′-AGCGCATTAGTTTATGATTTTTG-3′ and flG1R 5′-TTGTGAATTAGGGATCTTCATGTC-3′; amplifying a fragment of 0.7 kb) and WT 3′ (flG2F 5′-ATGCGCAAACCCGTTAAAT-3′ and flG2R 5′-TTTGATTCATTCCACTTTCCA-3′; amplifying fragment of 0.7 kb) and disrupted 5′ (flG1F and Pb103 5′-TAATTATATGTTATTTTATTTCCAC-3′; amplifying a fragment of 0.8 kb) and disrupted 3′ (flG2R and Pb106a 5′-TGCATGCACATGCATGTAAATAGC-3′; amplifying fragment of 0.9 kb) locus. PCR on DNA of complement was performed by using primers specific for INT3′ (Pb106a and flG4R 5′-GCAGAGAGAGCGTTAAAAACTATTG-3′, amplifying a fragment of 1.0 kb). RT-PCR was performed on RNA isolated from WT sporozoites. Primers 02-F (5′-AGGGTGACATTGAAGGGATG-3′) and 02-R (5′-ATTCCTCGGGATATTCCACC-3′) were used to amplify cDNA or genomic DNA derived from the PbACα gene, amplifying a fragment of 270 bp and 658 bp, respectively.

Genomic Southern hybridization

Genomic DNA of P. berghei (2 µg) was digested with HincII / EcoRI or NheI / EcoRI, separated on 0.9% agarose gel and then transferred onto a nylon membrane. DNA probe was labeled with digoxigenin using the DIG PCR labeling kit (Roche Diagnostics) using genomic DNA as template with the following primer pair, 5′-TCCTTCGTGGAATTTACACTTG-3′ and 5′-CCAGACGAGGAACTAATGCAG-3′. Signals were detected using the DIG/CPSD system (Roche Diagnostics).

Phenotype analysis of the PbACα- parasite during blood stage and mosquito stage development

Parasitemia in mice was determined by examination of a Giemsa-stained blood smear. Oocyst formation and sporozoite development were quantified in infected Anopheles stephensi mosquitoes as described [42]. The number of salivary gland sporozoites per mosquito was determined by dissecting salivary glands from 10 infected mosquitoes in each condition [43]. Blood stage infections were studied in mice (male Swiss Webster or C57/Bl6 mice, 20–25 g) infected with 200 µl of blood at 0.5% parasitemia. Experiment was performed twice showing similar results.

Gliding motility of sporozoites

Gliding motility of sporozoites was analyzed by counting the average number of circles performed by single sporozoites [44]. Sporozoites (2 × 104) were centrifuged for 10 min at 1,800 × g onto glass coverslips previously coated with anti-CS 3D11 antibody, followed by incubation for 2 h at 37°C and staining with biotin-labeled 3D11 antibody followed by incubation with avidin-FITC for sporozoite and trail visualization. Quantification was performed by counting the number of circles performed by 100 sporozoites in three independent coverslips. When indicated 3% mouse albumin was present in the assay.

Transwell filter assays

Hepa1-6 cells were cultivated on 3 µm pore diameter Transwell filters (Costar, Corning, New York) until they form a continuous monolayer. Empty coverslips were placed underneath the filters. Sporozoites (2×105) were added to filter insets containing Hepa1-6 cells or no cells. Coverslips were fixed after 2 h of incubation with sporozoites, before staining for surface TRAP to determine exocytosis. Experiment was performed twice showing similar results.

Sporozoite infectivity in vivo

Groups of three C57/Bl6 mice were given i.v. injections of 20,000 sporozoites. 40 h later, livers were harvested, total RNA was isolated, and malaria infection was quantified using reverse transcription followed by real-time PCR [31] using primers that recognize P. berghei–specific sequences within the 18S rRNA 5′-AAGCATTAAATAAAGCGAATACATCCTTAC and 5′-GGAGATTGGTTTTGACGTTTATGT. Experiment was performed three times showing similar results.

Accession numbers/ID numbers for genes and proteins

P. falciparum ACα: UniProtKB/TrEMBL accession number: Q8I7A1. PlasmoDB identifier: PF14_0043

P. berghei ACα: PlasmoDB identifier: PB001333.02.0. Complete PbACα sequences (contig 1047, 5680) were retrieved from Sanger sequencing genomics project. P. falciparum PKA: PlasmoDB identifier PFI1685w.

Supporting Information

Figure S1

Exocytosis of TRAP occurs in the apical end of sporozoites. P. berghei sporozoites were incubated on coverslips coated with anti-CS antibodies for 20 min before addition of forskolin. After another 30 min, sporozoites were fixed and stained for CS protein.

(5.64 MB TIF)

Figure S2

Control for sporozoite lysis. P. yoelii sporozoites (4 × 105) were incubated for 1 h with UD, forskolin (FSK) or 8Br-cAMP. Culture media (upper panel) and pellet containing sporozoites (lower panel) were analyzed by Western blot against myosin A tail domain interacting protein (MTIP), which is localized to the inner membrane complex. A unique band at 25 kDa was found.

(1.20 MB TIF)

Figure S3

Motility of sporozoites before and after exocytosis. Live P. yoelii sporozoites were observed directly under the microscope before or after addition of forskolin (A) or UD (B). Sporozoite motility was classified as immobile, twisting or gliding. There is a clear shift in sporozoite motility profile from gliding to immobile at later times after addition of the stimuli. As expected, a certain decrease in motility is observed over time even in control sporozoites, however, the decrease induced by the exocytosis stimuli is significantly more pronounced. No significant changes were observed in twisting motility.

(1.23 MB TIF)

Table S1

Determination of sporozoite viability after drug treatments. P. yoelii sporozoites were incubated in the different conditions indicated. Dead sporozoites were quantified using propidium iodide staining. An untreated control was performed for each condition because the background level of dead sporozoites may vary on each batch of dissected mosquitoes.

(1.05 MB TIF)

Acknowledgments

We thank Dabeiba Bernal-Rubio for providing Plasmodium infected mosquitoes. We thank T. Richie (Naval Medical Research Center, Silver Spring, MD) and E. Nardin (NYU School of Medicine, NY) for the mouse IgG1 and mouse anti-TRAP/SSP2 mAbs PfSSP2.1 and F3B5, respectively. We also thank Stefan Kappe for providing MTIP antiserum.

Footnotes

The authors have declared that no competing interests exist.

This work was supported by NIH grant R01 AI53698 to AR. LCS and RL are recipients of fellowships from Fundacao para a Ciencia e Tecnologia, Portugal.

References

1. Kappe S, Bruderer T, Gantt S, Fujioka H, Nussenzweig V, et al. Conservation of a gliding motility and cell invasion machinery in Apicomplexan parasites. J Cell Biol. 1999;147:937–944. [PMC free article] [PubMed]
2. Carruthers VB, Sibley LD. Mobilization of intracellular calcium stimulates microneme discharge in Toxoplasma gondii. Mol Microbiol. 1999;31:421–428. [PubMed]
3. Bumstead J, Tomley F. Induction of secretion and surface capping of microneme proteins in Eimeria tenella. Mol Biochem Parasitol. 2000;110:311–321. [PubMed]
4. Chen XM, O'Hara SP, Huang BQ, Nelson JB, Lin JJ, et al. Apical organelle discharge by Cryptosporidium parvum is temperature, cytoskeleton, and intracellular calcium dependent and required for host cell invasion. Infect Immun. 2004;72:6806–6816. [PMC free article] [PubMed]
5. Gantt S, Persson C, Rose K, Birkett AJ, Abagyan R, et al. Antibodies against thrombospondin-related anonymous protein do not inhibit Plasmodium sporozoite infectivity in vivo. Infect Immun. 2000;68:3667–3673. [PMC free article] [PubMed]
6. Carruthers VB. Proteolysis and Toxoplasma invasion. Int J Parasitol. 2006;36:595–600. [PubMed]
7. Huynh MH, Carruthers VB. Toxoplasma MIC2 is a major determinant of invasion and virulence. PLoS Pathog. 2006;2:e84. [PMC free article] [PubMed]
8. Sibley LD. Intracellular parasite invasion strategies. Science. 2004;304:248–253. [PubMed]
9. Mota MM, Hafalla JC, Rodriguez A. Migration through host cells activates Plasmodium sporozoites for infection. Nat Med. 2002;8:1318–1322. [PubMed]
10. Sultan AA, Thathy V, Frevert U, Robson KJ, Crisanti A, et al. TRAP is necessary for gliding motility and infectivity of plasmodium sporozoites. Cell. 1997;90:511–522. [PubMed]
11. Mota MM, Pradel G, Vanderberg JP, Hafalla JC, Frevert U, et al. Migration of plasmodium sporozoites through cells before infection. Science. 2001;291:141–144. [PubMed]
12. Lazarowski ER, Boucher RC, Harden TK. Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules. Mol Pharmacol. 2003;64:785–795. [PubMed]
13. Cabrita-Santos L, Diaz-Pulido O, Coppi A, Bernal-Rubio D, Merali S, et al. Molecular regulation of Plasmodium sporozoites exocytosis and infection.
14. Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, et al. International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev. 2006;58:281–341. [PMC free article] [PubMed]
15. Ishino T, Yano K, Chinzei Y, Yuda M. Cell-passage activity is required for the malarial parasite to cross the liver sinusoidal cell layer. PLoS Biol. 2004;2:E4. [PMC free article] [PubMed]
16. Guellaen G, Mahu JL, Mavier P, Berthelot P, Hanoune J. RMI 12330 A, an inhibitor of adenylate cyclase in rat liver. Biochimica et Biophysica Acta. 1977;484:465–475. [PubMed]
17. McNeil PL, Clarke MFS, Miyake K. John Wiley & Sons I, editor. Current Protocols in Cell Biology. 1999. Cell Motility, Cell Wound Assays. pp. 12.14.11–12.14.15.
18. Beraldo FH, Almeida FM, da Silva AM, Garcia CR. Cyclic AMP and calcium interplay as second messengers in melatonin-dependent regulation of Plasmodium falciparum cell cycle. J Cell Biol. 2005;170:551–557. [PMC free article] [PubMed]
19. Syin C, Parzy D, Traincard F, Boccaccio I, Joshi MB, et al. The H89 cAMP-dependent protein kinase inhibitor blocks Plasmodium falciparum development in infected erythrocytes. European Journal of Biochemistry. 2001;268:4842–4849. [PubMed]
20. Bahl A, Brunk B, Crabtree J, Fraunholz MJ, Gajria B, et al. PlasmoDB: the Plasmodium genome resource. A database integrating experimental and computational data. Nucleic Acids Res. 2003;31:212–215. [PMC free article] [PubMed]
21. Li J, Cox LS. Isolation and characterisation of a cAMP-dependent protein kinase catalytic subunit gene from Plasmodium falciparum. Mol Biochem Parasitol. 2000;109:157–163. [PubMed]
22. Muhia DK, Swales CA, Eckstein-Ludwig U, Saran S, Polley SD, et al. Multiple splice variants encode a novel adenylyl cyclase of possible plastid origin expressed in the sexual stage of the malaria parasite Plasmodium falciparum. J Biol Chem. 2003;278:22014–22022. [PubMed]
23. Weber JH, Vishnyakov A, Hambach K, Schultz A, Schultz JE, et al. Adenylyl cyclases from Plasmodium, Paramecium and Tetrahymena are novel ion channel/enzyme fusion proteins. Cell Signal. 2004;16:115–125. [PubMed]
24. Schultz JE, Klumpp S, Benz R, Schurhoff-Goeters WJ, Schmid A. Regulation of adenylyl cyclase from Paramecium by an intrinsic potassium conductance. Science. 1992;255:600–603. [PubMed]
25. Baker DA. Adenylyl and guanylyl cyclases from the malaria parasite Plasmodium falciparum. IUBMB Life. 2004;56:535–540. [PubMed]
26. Alberts B, Bray D, Lewis J, Raff M, Roberts K, et al. Molecular Biology of the Cell. Garland Publishing, Inc; 1983.
27. Allen RJ, Kirk K. The membrane potential of the intraerythrocytic malaria parasite Plasmodium falciparum. J Biol Chem. 2004;279:11264–11272. [PubMed]
28. Le Roch KG, Zhou Y, Blair PL, Grainger M, Moch JK, et al. Discovery of gene function by expression profiling of the malaria parasite life cycle. Science. 2003;301:1503–1508. [PubMed]
29. Vanderberg JP. Studies on the motility of Plasmodium sporozoites. J Protozool. 1974;21:527–537. [PubMed]
30. Scheller LF, Wirtz RA, Azad AF. Susceptibility of different strains of mice to hepatic infection with Plasmodium berghei. Infect Immun. 1994;62:4844–4847. [PMC free article] [PubMed]
31. Bruna-Romero O, Hafalla JC, Gonzalez-Aseguinolaza G, Sano G, Tsuji M, et al. Detection of malaria liver-stages in mice infected through the bite of a single Anopheles mosquito using a highly sensitive real-time PCR. Int J Parasitol. 2001;31:1499–1502. [PubMed]
32. Fujita-Yoshigaki J. Divergence and convergence in regulated exocytosis: the characteristics of cAMP-dependent enzyme secretion of parotid salivary acinar cells. Cellular Signalling. 1998;10:371–375. [PubMed]
33. Borodinsky LN, Spitzer NC. Second messenger pas de deux: the coordinated dance between calcium and cAMP. Sci STKE. 2006;2006:pe22. [PubMed]
34. Silvie O, Franetich JF, Boucheix C, Rubinstein E, Mazier D. Alternative invasion pathways for plasmodium berghei sporozoites. Int J Parasitol. 2007;37:173–182. [PubMed]
35. Read LK, Mikkelsen RB. Plasmodium falciparum-infected erythrocytes contain an adenylate cyclase with properties which differ from those of the host enzyme. Molecular & Biochemical Parasitology. 1991;45:109–119. [PubMed]
36. Mota MM, Rodriguez A. Plasmodium yoelii: efficient in vitro invasion and complete development of sporozoites in mouse hepatic cell lines. Exp Parasitol. 2000;96:257–259. [PubMed]
37. Ponnudurai T, Leeuwenberg AD, Meuwissen JH. Chloroquine sensitivity of isolates of Plasmodium falciparum adapted to in vitro culture. Trop Geogr Med. 1981;33:50–54. [PubMed]
38. Charoenvit Y, Fallarme V, Rogers WO, Sacci JB, Jr, Kaur M, et al. Development of two monoclonal antibodies against Plasmodium falciparum sporozoite surface protein 2 and mapping of B-cell epitopes. Infect Immun. 1997;65:3430–3437. [PMC free article] [PubMed]
39. Tsuji M, Mattei D, Nussenzweig RS, Eichinger D, Zavala F. Demonstration of heat-shock protein 70 in the sporozoite stage of malaria parasites. Parasitol Res. 1994;80:16–21. [PubMed]
40. Franke-Fayard B, Trueman H, Ramesar J, Mendoza J, van der Keur M, et al. A Plasmodium berghei reference line that constitutively expresses GFP at a high level throughout the complete life cycle. Mol Biochem Parasitol. 2004;137:23–33. [PubMed]
41. de Koning-Ward TF, Fidock DA, Thathy V, Menard R, van Spaendonk RM, et al. The selectable marker human dihydrofolate reductase enables sequential genetic manipulation of the Plasmodium berghei genome. Mol Biochem Parasitol. 2000;106:199–212. [PubMed]
42. Sinden RE. In: Molecular Biology of Insect Diseases Vectors: A Methods Manual; Crampton JM, Beard CB, Louis C, editors. London: Chapman and Hall; 1997. pp. 67–91.
43. Ozaki LS, Gwadz RW, Godson GN. Simple centrifugation method for rapid separation of sporozoites from mosquitoes. J Parasitol. 1984;70:831–833. [PubMed]
44. Stewart MJ, Vanderberg JP. Malaria sporozoites leave behind trails of circumsporozoite protein during gliding motility. J Protozool. 1988;35:389–393. [PubMed]

Articles from PLoS Pathogens are provided here courtesy of Public Library of Science
PubReader format: click here to try

Formats: